Gross Margin % is calculated as gross profit divided by its revenue. Ebos Group's Gross Profit for the
six
months ended in Dec. 2023 was $547 Mil. Ebos Group's Revenue for the
six
months ended in Dec. 2023 was $4,411 Mil. Therefore, Ebos Group's Gross Margin % for the quarter that ended in Dec. 2023 was 12.40%.
The historical rank and industry rank for Ebos Group's Gross Margin % or its related term are showing as below:
EBOSF'
s Gross Margin % Range Over the Past 10 Years
Min: 9.62 Med: 10.65 Max: 12.76
Current: 12.6
During the past 13 years, the highestGross Margin % of Ebos Group was 12.76%. The lowest was 9.62%. And the median was 10.65%.
EBOSF's Gross Margin % is ranked worse than 58.33% of 96
companies
in the Medical Distribution industry
Industry Median: 16.315
vs EBOSF: 12.60
Ebos Group had a gross margin of 12.40% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Ebos Group was 1.80% per year.
Ebos Group Gross Margin % Historical Data
The historical data trend for Ebos Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ebos Group's Gross Margin %
For the Medical Distribution subindustry, Ebos Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group's Gross Margin % Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Ebos Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Ebos Group (OTCPK:EBOSF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Ebos Group had a gross margin of 12.40% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Ebos Group Gross Margin % Related Terms
Thank you for viewing the detailed overview of Ebos Group's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EBOSF has been successfully added to your 